Literature DB >> 12942343

Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient.

Verena Materna1, Hermann Lage2.   

Abstract

Dubin-Johnson syndrome (DJS) is an autosomal recessive disorder characterized by conjugated hyperbilirubinemia and caused by mutations of the ATP-binding cassette (ABC) transporter encoding gene MRP2/cMOAT/ABCC2. Previous studies reported on mutations in DJS patients and polymorphisms in healthy human individuals. The genomic DNA sequence of a female Caucasian DJS patient was analyzed by DNA sequencing and revealed the identification of a homozygous missense mutation C2302T. This DJS-causing alteration results in an amino acid exchange Arg768Trp.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942343     DOI: 10.1007/s10038-003-0057-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28.

Authors:  Masaya Itoda; Yoshiro Saito; Akiko Soyama; Mayumi Saeki; Norie Murayama; Seiichi Ishida; Kimie Sai; Michiyo Nagano; Hiroshi Suzuki; Yuichi Sugiyama; Shogo Ozawa; Jun-ichi Sawada Ji
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

Review 2.  Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition.

Authors:  Hiroshi Suzuki; Yuichi Sugiyama
Journal:  Adv Drug Deliv Rev       Date:  2002-11-18       Impact factor: 15.470

Review 3.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

Authors:  J König; A T Nies; Y Cui; I Leier; D Keppler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

4.  Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells.

Authors:  A Eva; K C Robbins; P R Andersen; A Srinivasan; S R Tronick; E P Reddy; N W Ellmore; A T Galen; J A Lautenberger; T S Papas; E H Westin; F Wong-Staal; R C Gallo; S A Aaronson
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

5.  Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.

Authors:  S Toh; M Wada; T Uchiumi; A Inokuchi; Y Makino; Y Horie; Y Adachi; S Sakisaka; M Kuwano
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

6.  Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.

Authors:  S Ito; I Ieiri; M Tanabe; A Suzuki; S Higuchi; K Otsubo
Journal:  Pharmacogenetics       Date:  2001-03

7.  Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.

Authors:  M Wada; S Toh; K Taniguchi; T Nakamura; T Uchiumi; K Kohno; I Yoshida; A Kimura; S Sakisaka; Y Adachi; M Kuwano
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

8.  Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Yukie Miura; Chie Ogawa; Saori Kawauchi; Shoko Higuchi; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

9.  Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome.

Authors:  Kenkichi Hashimoto; Takeshi Uchiumi; Toshikazu Konno; Takuya Ebihara; Takanori Nakamura; Morimasa Wada; Shotaro Sakisaka; Fumio Maniwa; Teruo Amachi; Kazumitsu Ueda; Michihiko Kuwano
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

10.  Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.

Authors:  M Dietel; H Arps; H Lage; A Niendorf
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

View more
  3 in total

1.  Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.

Authors:  T M Bosch; V D Doodeman; P H M Smits; I Meijerman; J H M Schellens; J H Beijnen
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 2.  Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Authors:  Tessa M Bosch; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.

Authors:  Manuel Tonigold; Annette Rossmann; Marie Meinold; Michael Bette; Melanie Märken; Katharina Henkenius; Anne C Bretz; Gavin Giel; Chengzhong Cai; Fiona R Rodepeter; Vladimir Beneš; Reidar Grénman; Thomas E Carey; Hermann Lage; Thorsten Stiewe; Andreas Neubauer; Jochen A Werner; Cornelia Brendel; Robert Mandic
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-10       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.